Scopus BioPharma Inc. (SCPS)

Scopus BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	0.36	0.12	7.94	1.83	0.04	0
Cash & Short-Term Investments	0.36	0.12	7.94	1.83	0.04	0
Cash Growth	-68.69%	-98.43%	333.54%	4885.71%	2113.67%	-98.95%
Other Receivables	-	-	-	-	-	0.03
Receivables	-	-	-	-	-	0.03
Prepaid Expenses	0.13	0.27	0.24	0.14	0.08	0.1
Other Current Assets	-	-	-	-	0.65	-
Total Current Assets	0.5	0.39	8.18	1.97	0.77	0.13
Property, Plant & Equipment	0	0	0	0	0	-
Total Assets	0.5	0.39	8.19	1.97	0.77	0.13
Accounts Payable	0.17	0.18	0.12	0.09	0.16	-
Accrued Expenses	10.74	7.03	4.05	1.43	0.69	0.11
Current Portion of Long-Term Debt	-	-	-	2.28	-	-
Other Current Liabilities	0.09	0.25	-	-	-	0.02
Total Current Liabilities	11	7.45	4.17	3.81	0.85	0.14
Total Liabilities	11	7.45	4.17	3.81	0.85	0.14
Common Stock	0.04	0.02	0.02	0.01	0.01	0.01
Additional Paid-In Capital	48.62	46.52	45.54	14.22	3.58	0.94
Retained Earnings	-58.13	-53.06	-41.46	-14.5	-3.64	-0.95
Comprensive Income & Other	0.02	-0.04	-0.09	-1.57	-0.03	-0.01
Total Common Equity	-9.45	-6.56	4.02	-1.83	-0.08	-0.01
Minority Interest	-1.05	-0.5	-	-	-	-
Shareholders' Equity	-10.5	-7.06	4.02	-1.83	-0.08	-0.01
Total Liabilities & Equity	0.5	0.39	8.19	1.97	0.77	0.13
Total Debt	-	-	-	2.28	-	-
Net Cash (Debt)	0.36	0.12	7.94	-0.45	0.04	0
Net Cash Growth	-68.69%	-98.43%	-	-	2113.67%	-98.95%
Net Cash Per Share	0.01	0.01	0.46	-0.03	0.00	0.00
Filing Date Shares Outstanding	42.08	39.58	21.09	15.73	12.51	10.77
Total Common Shares Outstanding	39.78	21.09	21.09	14.58	12.51	10.77
Working Capital	-10.51	-7.06	4.01	-1.83	-0.09	-0.01
Book Value Per Share	-0.24	-0.31	0.19	-0.13	-0.01	-0.00
Tangible Book Value	-9.45	-6.56	4.02	-1.83	-0.08	-0.01
Tangible Book Value Per Share	-0.24	-0.31	0.19	-0.13	-0.01	-0.00

Source: S&P Capital IQ. Standard template. Financial Sources.